(0) SAN DIEGO, CA / ACCESSWIRE / May 24, 2021 / Ainos, Inc., f/k/a Amarillo Biosciences, Inc. ("we", "our", or the "Company"), (OTC PINK:AIMD), is pleased to announce that the Financial Industry Regulatory Authority, Inc. ("FINRA") approved the Company's name change to "Ainos, Inc." and "AIMD" as its new ticker symbol. Effective today, the Company's common stock will trade under the symbol "AIMD" and the new CUSIP number identifying our common stock is 00902F105. These changes follow the Company's announcement in April 21, 2021 of the successful completion of a securities purchase transaction with Ainos, Inc., a Cayman Islands corporation (the "Investor" or "Ainos KY").